We are live on ! Find out more
AIP

Arrowpoint Investment Partners Portfolio holdings

AUM $113M
1-Year Est. Return 73.91%
This Fund
S&P 500
This Quarter Est. Return
+9.13%
1 Year Est. Return
+73.91%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$113M
AUM Growth
-$566M
Cap. Flow
-$573M
Cap. Flow %
-509.53%
Top 10 Hldgs %
59.57%
Holding
143
New
38
Increased
22
Reduced
20
Closed
61

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$9.34M
2
ASX icon
ASE Group
ASX
+$3.77M
3
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$2.84M
4
AXSM icon
Axsome Therapeutics
AXSM
+$2.47M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$2.39M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$82.5M
2
JNJ icon
Johnson & Johnson
JNJ
+$71.3M
3
MSFT icon
Microsoft
MSFT
+$70.1M
4
C icon
Citigroup
C
+$54.1M
5
HD icon
Home Depot
HD
+$54M

Sector Composition

Rank Sector Weight
1 Healthcare 42.66%
2 Communication Services 8.03%
3 Technology 3.81%
4 Financials 0.8%
5 Materials 0.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IWM icon
26
PUT
iShares Russell 2000 ETF
IWM
$82.2B
$867K 0.77%
+3,500
New +$903K
BIIB icon
27
Biogen
BIIB
$30.8B
$863K 0.77%
4,706
+1,851
+65% +$341K
TEVA icon
28
Teva Pharmaceuticals
TEVA
$37.5B
$777K 0.69%
25,805
-126,907
-83% -$4.08M
RVMD icon
29
Revolution Medicines
RVMD
$38.1B
$775K 0.69%
7,971
+4,771
+149% +$482K
XLU icon
30
State Street Utilities Select Sector SPDR ETF
XLU
$23.5B
$753K 0.67%
16,400
-35,300
-68% -$1.58M
OSG
31
Octave Specialty Group
OSG
$275M
$647K 0.58%
139,168
-63,843
-31% -$366K
TWST icon
32
Twist Bioscience
TWST
$5.68B
$640K 0.57%
13,476
+3,484
+35% +$156K
MDGL icon
33
Madrigal Pharmaceuticals
MDGL
$12.6B
$624K 0.55%
1,192
+821
+221% +$392K
TLT icon
34
iShares 20+ Year Treasury Bond ETF
TLT
$42.1B
$615K 0.55%
+7,100
New +$624K
BNTX icon
35
BioNTech
BNTX
$23.2B
$612K 0.54%
+6,890
New +$708K
NTRA icon
36
Natera
NTRA
$38.6B
$594K 0.53%
+2,970
New +$639K
AXGN icon
37
Axogen
AXGN
$2.12B
$539K 0.48%
16,273
-2,929
-15% -$95.2K
XLI icon
38
State Street Industrial Select Sector SPDR ETF
XLI
$33.3B
$534K 0.47%
3,300
+500
+18% +$83.9K
COGT icon
39
Cogent Biosciences
COGT
$6.48B
$531K 0.47%
13,784
+6,431
+87% +$237K
XLE icon
40
State Street Energy Select Sector SPDR ETF
XLE
$38.2B
$521K 0.46%
8,500
+6,700
+372% +$359K
XLP icon
41
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.6B
$516K 0.46%
+6,300
New +$531K
CYTK icon
42
Cytokinetics
CYTK
$10.9B
$487K 0.43%
7,388
+2,908
+65% +$185K
GMAB icon
43
Genmab
GMAB
$17.8B
$430K 0.38%
16,030
-27,198
-63% -$815K
BBIO icon
44
BridgeBio Pharma
BBIO
$15.7B
$430K 0.38%
5,785
+2,860
+98% +$207K
TNGX icon
45
Tango Therapeutics
TNGX
$4.5B
$428K 0.38%
+20,463
New +$285K
COO icon
46
Cooper Companies
COO
$14.3B
$422K 0.37%
5,896
-4,538
-43% -$359K
LLY icon
47
Eli Lilly
LLY
$1.04T
$407K 0.36%
442
-8,751
-95% -$8.87M
ERAS icon
48
Erasca
ERAS
$6.6B
$402K 0.36%
+24,847
New +$294K
LITE icon
49
Lumentum
LITE
$54.9B
$395K 0.35%
562
-10,925
-95% -$6M
ILMN icon
50
Illumina
ILMN
$28.8B
$373K 0.33%
+3,026
New +$397K
1
2
3 4 5

Similar funds

MWP
Momentum Wealth Planning Estero, Florida $113M AUM 26.08% 1-Year Est. Return
AIC
Argus Investors Counsel New York $112M AUM 25.83% 1-Year Est. Return
OP
Oath Planning Tulsa, Oklahoma $113M AUM
VCM
Veradace Capital Management Dallas, Texas $112M AUM
TBNY
Trustco Bank (New York) Albany, New York $113M AUM 34.59% 1-Year Est. Return
GCWM
Graham Capital Wealth Management Washington D.c., District of Columbia $113M AUM 11.26% 1-Year Est. Return
PFS
Professional Financial Solutions Falls Chruch, Virginia $112M AUM
UOWF
University of Wisconsin Foundation Madison, Wisconsin $113M AUM 23.15% 1-Year Est. Return

Arrowpoint Investment Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Arrowpoint Investment Partners held 143 positions worth $113M, down 83% from $679M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Arrowpoint Investment Partners withdrew a net $573M in Q1 2026, closing 61 positions and reducing 20 holdings. Its most notable exit was NVIDIA, an estimated $82.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, up from 18% a quarter earlier, followed by Communication Services and Technology.

Against the trend, Arrowpoint Investment Partners opened a new position in ASE Group worth $3.89M.

  • Arrowpoint Investment Partners's largest Q1 2026 buy was ASE Group: 179,512 shares worth $3.89M.
  • Arrowpoint Investment Partners added most to Alphabet (Google) Class A in Q1 2026, an estimated $9.34M increase.
  • Arrowpoint Investment Partners's biggest Q1 2026 reduction was Johnson & Johnson, cutting an estimated $71.3M.
  • Arrowpoint Investment Partners fully exited NVIDIA in Q1 2026, selling an estimated $82.5M.
  • Arrowpoint Investment Partners's ten largest holdings make up 60% of its $113M portfolio in Q1 2026.
  • Arrowpoint Investment Partners opened 38 new positions and closed 61 in Q1 2026.
  • Arrowpoint Investment Partners's portfolio value fell 83% quarter-over-quarter to $113M.

Based on Arrowpoint Investment Partners's 13F filing for Q1 2026, filed 14 May 2026.